NCT02577562

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Zenith® Fenestrated AAA Endovascular Graft Clinical Study

• Status: Approved For Marketing
• Phase: —
• Study type: Expanded Access
• Enrollment: —
• Sponsor: Cook Group Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Conditions

• Abdominal Aortic Aneurysms
• Aorto-iliac Aneurysms
• Juxtarenal Aneurysms

Interventions

Type	Name	Description
DEVICE	Zenith® Fenestrated AAA Endovascular Graft	The Zenith® Fenestrated AAA Endovascular Graft with the H\&L-B One-Shot™ Introduction System is indicated for the endovascular treatment of patients with abdominal aortic or aortoiliac aneurysms having morphology suitable for endovascular repair

Timeline

• First posted: 2015-10-16
• Last updated: 2017-11-24

Locations

15 sites across 1 country: United States